Eli Lilly said on Tuesday Japan's health ministry has approved donanemab, its drug for Alzheimer's disease, providing ...
Two new drug treatments prove effective in forestalling the start of early onset Alzheimer's; Roskamp will eventually offer ...
The European Medicines Agency’s human medicines committee is re-examining the marketing authorisation application for the ...
From biochemist to executive supplier to angel investor to company founder and CEO, Maria Maccecchini, Ph.D.’s ...
From Eli Lilly to Karuna Therapeutics to current owner Bristol Myers Squibb, the newly approved schizophrenia drug had quite ...
(Reuters) - Eli Lilly said on Tuesday Japan's health ministry has approved donanemab, its drug for Alzheimer's disease, providing patients with another treatment option after Eisai and Biogen's ...
A report published Wednesday in The BMJ questioned the safety and effectiveness of the Alzheimer’s disease drug Kisunla ...
In the ensuing years there have been countless near-misses with promising new drugs to treat Alzheimer's ... and Company and marketed under the brand name Kisunla. In July 2023, the FDA approved ...
After a dementia diagnosis, preparing key legal documents early helps families focus on the quality of life for their loved ...
These opposing statements sum up the entrenched positions on the recently introduced drugs for Alzheimer's, the most common form of dementia which millions of people across the world suffer from.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback